Transurethral needle ablation of the prostate.
OBJECTIVE
The review aims at reviewing the evidence published in the peer review literature or otherwise available with particular focus on articles published over the last 2 years on the transurethral needle ablation of the prostate in the treatment of benign prostatic hyperplasia. Prospective noncomparative and comparative studies as well as meta-analyses were considered. Information from the European Real Life database on transurethral needle ablation was also included.


RESULTS
The evidence currently available confirms a clinically relevant improvement of lower urinary tract symptoms and quality of life. Impact on voiding dynamics including flow rates, detrusor pressure at maximum flow and postvoid residual, as well on prostate volume, remains marginal.


CONCLUSIONS
All major guidelines in the management of lower urinary tract symptoms in patients with benign prostatic enlargement include transurethral needle ablation of the prostate as a valuable treatment option in patients with severe symptoms and low degree of bladder outlet obstruction, patients at high risk for surgery and patients who wish to avoid surgery or regional/general anaesthesia.
Tubaro
Andrea
A
Department of Urology, 2nd School of Medicine, La Sapienza University, Rome, Italy. andrea.tubaro@tin.it
De Nunzio
Cosimo
C
Miano
Roberto
R
D006801:Humans; D008297:Male; D019060:Minimally Invasive Surgical Procedures; D011467:Prostate / Q000601:surgery*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000295:instrumentation / Q000379:methods*